Brief: Alzinova Starts Extension Part Of Phase 1b Study With ALZ-101

Alzinova AB

29/05/2023 12:09

May 29 (Reuters) - Alzinova AB  ALZ.ST :
    * FIRST PATIENT DOSED IN THE EXTENSION PART OF THE PHASE 1B
STUDY
WITH ALZ-101
    * EXTENSION PART OF ONGOING PHASE 1B STUDY HAS BEEN
INITIATED BY
DOSING FIRST PATIENT WITH VACCINE CANDIDATE ALZ-101

Source text for Eikon:  ID:nMFN6lXyQF 
Further company coverage:  ALZ.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))